A drug with the SMILES CCN1CCN(C(=O)c2cn(CC)c3ccc(S(=O)(=O)N(C)C)cc3c2=O)CC1 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 10.017\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CCN1CCN(C(=O)c2cn(CC)c3ccc(S(=O)(=O)N(C)C)cc3c2=O)CC1
CCN1CCN(C(=O)c2cn(CC)c3ccc(S(=O)(=O)N(C)C)cc3c2=O)CC1
1-ethyl-3-(4-ethylpiperazine-1-carbonyl)-N,N-dimethyl-4-oxoquinoline-6-sulfonamide